Metabolic bone disease: a continued challenge in extremely low birth weight infants.

JPEN J Parenter Enteral Nutr

Division of Critical Care, Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA

Published: November 2014

Background: Metabolic bone disease (MBD) is an important prematurity-related morbidity, but remains inadequately investigated in extremely low birth weight (ELBW) infants, the group most at risk. The objective was to describe the incidence and associated risk factors of MBD in ELBW infants.

Methods: Retrospective analysis of all ELBW infants admitted between January 2005 and December 2010 who survived > 8 weeks. MBD was defined as the presence of osteopenia or rickets in radiographs.

Results: Of the 230 infants included in the study, 71 (30.9%) developed radiological evidence of MBD (cases) of which 24/71 (33.8%) developed spontaneous fractures. MBD and fractures were noted at mean postnatal ages of 58.2 ± 28 and 100.0 ± 61 days, respectively. Compared with controls, cases were smaller at birth (664.6 ± 146 g vs 798.1 ± 129 g), more premature (25.0 ± 1.8 vs 26.4 ± 1.9 weeks), more frequently associated with mechanical ventilation, chronic lung disease, parenteral nutrition days, cholestasis, furosemide, postnatal steroids, and antibiotics use (all P < .01). Cases had lower average weekly intake of calcium, phosphorous, vitamin D, protein, and calories during the first 8 weeks of life compared with controls. Cases with MBD, compared with controls, had higher mortality (14.1 vs 4.4%) and longer hospital stay (140.2 ± 51 vs 101.0 ± 42 days; P < .01).

Conclusions: MBD remains an important morbidity in ELBW infants despite advances in neonatal nutrition. Further research is needed to optimize the management of chronic lung disease and early nutrition in ELBW infants.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0148607113499590DOI Listing

Publication Analysis

Top Keywords

elbw infants
16
compared controls
12
metabolic bone
8
bone disease
8
extremely low
8
low birth
8
birth weight
8
controls cases
8
chronic lung
8
lung disease
8

Similar Publications

Background: Studies on how birth body mass index (BMI) affects health outcomes in preterm infants are relatively limited.

Aim: To analyze the association between BMI at birth and neonatal health outcomes in extremely low and very low birth weight preterm infants in China.

Methods: Used data from the Chinese Premature Infant Informatization Platform (2022-2023).

View Article and Find Full Text PDF

: To obtain bioelectrical data to assess nutritional status for extremely low-birth-weight (ELBW) infants upon reaching term-corrected age. : A descriptive, observational, prospective, and single-center study, which included ELBW preterm infants was performed. The study variables collected were gestational age, sex, and anthropometry at birth and at term-corrected age.

View Article and Find Full Text PDF
Article Synopsis
  • Very low birth weight (VLBW) infants create significant caregiving challenges for families, making family resilience essential for managing stress and adapting after discharge.
  • The study aimed to assess how family resilience affects mothers of VLBW and extremely low birth weight (ELBW) infants, focusing on aspects like social support, family functioning, and parenting stress over 3 and 6 months.
  • Results showed that mothers reported moderate-to-high family resilience levels, with social support and parenting stress being strong indicators of resilience, highlighting the importance of support systems in navigating the challenges of caring for premature infants.
View Article and Find Full Text PDF
Article Synopsis
  • The study explored the role of intratracheal budesonide combined with surfactant in reducing death or bronchopulmonary dysplasia (BPD) in extremely low birth weight (ELBW) infants with respiratory distress syndrome (RDS).
  • The results showed no significant difference in the rates of death or BPD between the group that received the combination treatment and the historical group that received surfactant alone.
  • Although the combination treatment was found to be safe and feasible, further larger studies are needed to confirm any potential benefits.
View Article and Find Full Text PDF

Objective: Acetaminophen and indomethacin are used for medical management of a patent ductus arteriosus. This study compared the efficacy of these agents in ELBW infants.

Study Design: This was a retrospective study of all courses of indomethacin and acetaminophen.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!